Pyrazolo[1,5-a]pyridin-3-ylmethanamine dihydrochloride

Catalog No. :
ACHLES996
CAS No. :
1187932-00-8
Molecular Formula :
C8H11Cl2N3
Molecular Weight :
220.10

IUPAC Name:pyrazolo[1,5-a]pyridin-3-ylmethanamine dihydrochloride

Pyrazolo[1,5-a]pyridin-3-ylmethanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$167.00Login to see priceInquiryInquiry
250mg95%$231.00Login to see priceInquiryInquiry
1g95%$430.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyrazolo[1,5-a]pyridin-3-ylmethanamine dihydrochloride
IUPAC Namepyrazolo[1,5-a]pyridin-3-ylmethanamine dihydrochloride
Molecular FormulaC8H11Cl2N3
Molecular Weight220.10
SMILESNCC1=C2C=CC=CN2N=C1.[H]Cl.[H]Cl
InChI KeyIYDFIGRTKJXLJD-UHFFFAOYSA-N
SynonymPyrazolo[1,5-a]pyridine-3-methanamine, hydrochloride (1:2);Pyrazolo[1,5-a]pyridin-3-ylmethanamine hydrochloride;C-Pyrazolo[1,5-a]pyridin-3-yl-methylamine dihydrochloride;Pyrazolo[1,5-a]pyridine-3-methanamine dihydrochloride
CAS No.1187932-00-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHLES996 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQMY283 route compound structure diagram
    ACNQMY28325627-89-8 In Stock
  2. Then
  3. ACHLES996 route product structure diagram
    ACHLES9961187932-00-8
Inquiry

2. ACHLES996 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. ACMRGX690 route compound structure diagram
    ACMRGX69073957-66-1 In Stock
  4. Then
  5. ACHLES996 route product structure diagram
    ACHLES9961187932-00-8
Inquiry

Comments (0)